Fiduciary Trust’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.05M | Buy |
4,765
+1,242
| +35% | +$344K | 0.01% | 410 |
|
|
2026
Q1 | $1.04M | Buy |
3,523
+126
| +4% | +$37.4K | 0.01% | 412 |
|
|
2025
Q4 | $928K | Buy |
3,397
+107
| +3% | +$29.1K | 0.01% | 429 |
|
|
2025
Q3 | $889K | Sell |
3,290
-31
| -0.9% | -$8.44K | 0.01% | 436 |
|
|
2025
Q2 | $915K | Buy |
3,321
+431
| +15% | +$117K | 0.01% | 417 |
|
|
2025
Q1 | $767K | Sell |
2,890
-253
| -8% | -$62.4K | 0.01% | 448 |
|
|
2024
Q4 | $730K | Buy |
3,143
+311
| +11% | +$71.5K | 0.01% | 414 |
|
|
2024
Q3 | $625K | Buy |
2,832
+12
| +0.4% | +$2.48K | 0.01% | 443 |
|
|
2024
Q2 | $554K | Buy |
2,820
+175
| +7% | +$36.2K | 0.01% | 436 |
|
|
2024
Q1 | $569K | Sell |
2,645
-164
| -6% | -$34.5K | 0.01% | 434 |
|
|
2023
Q4 | $592K | Buy |
2,809
+78
| +3% | +$16.6K | 0.01% | 421 |
|
|
2023
Q3 | $547K | Buy |
2,731
+90
| +3% | +$17.9K | 0.01% | 417 |
|
|
2023
Q2 | $489K | Sell |
2,641
-79
| -3% | -$14.6K | 0.01% | 446 |
|
|
2023
Q1 | $521K | Sell |
2,720
-2
| -0.1% | -$362 | 0.01% | 431 |
|
|
2022
Q4 | $458K | Sell |
2,722
-501
| -16% | -$87.1K | 0.01% | 466 |
|
|
2022
Q3 | $571K | Buy |
3,223
+227
| +8% | +$44.9K | 0.01% | 417 |
|
|
2022
Q2 | $613K | Sell |
2,996
-25
| -0.8% | -$5.3K | 0.01% | 415 |
|
|
2022
Q1 | $719K | Hold |
3,021
| – | – | 0.01% | 407 |
|
|
2021
Q4 | $690K | Buy |
3,021
+55
| +2% | +$12.1K | 0.01% | 415 |
|
|
2021
Q3 | $573K | Buy |
2,966
+543
| +22% | +$110K | 0.01% | 448 |
|
|
2021
Q2 | $515K | Sell |
2,423
-2,047
| -46% | -$432K | 0.01% | 463 |
|
|
2021
Q1 | $913K | Buy |
4,470
+2,400
| +116% | +$473K | 0.02% | 346 |
|
|
2020
Q4 | $377K | Buy |
2,070
+305
| +17% | +$51.9K | 0.01% | 469 |
|
|
2020
Q3 | $296K | Sell |
1,765
-1,530
| -46% | -$258K | 0.01% | 468 |
|
|
2020
Q2 | $536K | Sell |
3,295
-1,166
| -26% | -$209K | 0.01% | 369 |
|
|
2020
Q1 | $771K | Buy |
4,461
+2,165
| +94% | +$431K | 0.02% | 287 |
|
|
2019
Q4 | $461K | Buy |
+2,296
| New | +$471K | 0.01% | 394 |
|
|
2017
Q3 | – | Sell |
-839
| Closed | -$105K | – | 443 |
|
|
2017
Q2 | $105K | Buy |
+839
| New | +$100K | ﹤0.01% | 529 |
|
Other funds holding CME
Fiduciary Trust's CME Position: Q2 2026 in Review
Fiduciary Trust increased its CME Group (CME) stake by 35% in Q2 2026, buying an estimated $344K and bringing the position to 4,765 shares worth $1.05M. The position accounts for 0.01% of the portfolio, ranked #410.
Fiduciary Trust first reported a position in CME in Q2 2017 and has held it in 28 quarters since. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Fiduciary Trust held 4,765 shares of CME Group worth $1.05M as of Q2 2026.
- Fiduciary Trust bought 1,242 CME Group shares in Q2 2026, an estimated $344K.
- CME Group made up 0.01% of Fiduciary Trust's portfolio in Q2 2026, its #410 holding.
- Fiduciary Trust first reported a position in CME Group in Q2 2017 and has held it in 28 quarters since.
- 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.